Structure Therapeutics Inc. American Intrinsic Value

GPCR

Structure Therapeutics Inc. American fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Structure Therapeutics Inc. American today, so there is nothing to project yet.

Peers

Biotechnology · Pick stocks to compare with GPCR

CompareIntrinsic value

NEWBRY.XSTONewbury Pharmaceuticals AB

€0.14+60.18%40

HPHA.XETRHeidelberg Pharma AG

€2.11-1.40%10

MEDCL.XPARMedincell SA

€26.36+0.38%40

ZTEKZentek Ltd.

€0.34+0.00%40

XTXXFAdastra Holdings Ltd.

€0.08+0.00%40

XRTXXORTX Therapeutics Inc.

$1.00-2.91%10

VALNValneva SE Sponsored ADR

$5.45-4.55%0

TRIBTrinity Biotech plc Sponsored ADR

$6.56-1.13%10

Held by ETFs

GPCR is in 18 US ETFs. The largest of them, with GPCR's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GPCR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.